2m 2m 2m 2m 2m 2m 2m
Xenon Pharma (XENE)
NASDAQ
$36.35-$0.15 (-0.41%)
Price as of Oct 22, 2026 7:32 PM EDT- $3.5BMarket Cap
- -14.77%1-Year Change
- BiotechnologyIndustry
Xenon Pharma (XENE)
$36.35-$0.15 (-0.41%)
XENE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.50 | ||
Change | -$0.32 (-0.88%) | ||
Open | $35.92 | ||
High | $36.90 | ||
Low | $35.70 | ||
Previous Close | $35.95 | ||
Volume | 1,375,539 | ||
30-Day Average Volume | 2,090,006 | ||
1-Week Change | 6.05% | ||
1-Month Change | -7.80% | ||
1-Year Change | -14.77% | ||
3-Year Change | 8.15% | ||
5-Year Change | 17.37% | ||
Fundamentals | |||
Shares Outstanding | 96.8M | ||
Total Assets | $1.3B | ||
Market Cap | $3.5B | ||
Enterprise Value | $3.4B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$110.7M | ||
Free Cash Flow | -$95.7M | ||
EBIT | -$111.3M | ||
EBITDA | -$110.8M | ||
Net Working Capital | $900.9M | ||
EPS | -$1.11 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -32 | ||
PEG | -6 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue